Trial Profile
Effect of rebamipide in coronary artery disease patients with dual antiplatelet induced gastrointestinal tract injury
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2018
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Gastric ulcer
- Focus Therapeutic Use
- Sponsors Thai otsuka pharmaceutical
- 19 Jun 2018 New trial record